Virtus Investment Advisers’s SELLAS Life Sciences SLS Stock Holding History

Virtus Investment Advisers’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$617K	Buy	+41,788	New	+$288K	0.14%	200

Other funds holding SLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Virtus Investment Advisers's SLS Position: Q2 2026 in Review

Virtus Investment Advisers opened a new position in SELLAS Life Sciences (SLS) in Q2 2026: 41,788 shares worth $617K. The stake represents 0.14% of the portfolio and ranks #200 among its holdings.

192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

Virtus Investment Advisers held 41,788 shares of SELLAS Life Sciences worth $617K as of Q2 2026.
SELLAS Life Sciences was a new Virtus Investment Advisers position in Q2 2026.
SELLAS Life Sciences made up 0.14% of Virtus Investment Advisers's portfolio in Q2 2026, its #200 holding.
192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.